Press Releases

NASDAQ: EUTSXV: EUwww.encoreuranium.comDALLAS, June 18, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ:EU) (TSXV:EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced that the Bureau of Land Management ("BLM") has issued a final decision and approved the Dewey Burdock Uranium Project, authorizing the Company to commence infrastructure construction for the Dewey Burdock Uranium In-Situ Recovery (ISR) Project in Southwest South Dakota. With the execution of the final Environmental Assessment (EA) and Finding of No Significant Impact, the BLM authorizes enCore's wholly owned subsidiary Powertech Inc.

IRVINE, Calif., June 18, 2026 /PRNewswire/ -- There's a particular kind of exhaustion that comes with long family road trips. The engine drone that creeps into your skull somewhere around hour three. The faint smell of gasoline that lingers after every fuel stop. The constant mental load of monitoring traffic, adjusting cruise control, and trying to hold a conversation at the same time. Most families have simply accepted this as the price of getting somewhere together. VinFast thinks differently.The VF 8, the Vietnamese automaker's flagship electric SUV now available across the United States, is built around a straightforward p

$94.7 Million USD Estimated Combined Value of Potential Tax Credits97 MW DC of Solar and 42 MWh of Energy Storage Across New York and PennsylvaniaProjects Expected to Power Equivalent of 11,000 HomesTORONTO, June 18, 2026 /PRNewswire/ - PowerBank Corporation (NASDAQ:PBK) (Cboe CA: PBK) (FSE: 103) ("PowerBank" or the "Company"), a leader in independent energy development and asset ownership in North America, is pleased to confirm the completion of equipment procurement agreements totaling $242.3 million USD in construction value across 23 distributed solar and energy storage projects (the "Projects") in New York and Pennsylvania through its wholly owned subsidiary Abundant Solar Power Inc. Th

AIRO Group Holdings, Inc. (NASDAQ:AIRO), a next-generation aerospace and defense company, in combination with Sky-Watch A/S, its wholly owned subsidiary, today announced the public unveiling of its RQ-70, a new deep-reach intelligence, surveillance and reconnaissance (ISR) drone, extending ISR capabilities beyond the immediate tactical frontline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618945644/en/RQ-70 The announcement was made at Eurosatory 2026, a global event for defense and security held in Paris. AIRO expects the RQ-70 to enter full-scale production in January 2027, leveraging the Company's existing manufactur

PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its HyperPlate™ XM Dynamic Compression Locking Implant. HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking screws into the titanium compression implants to deliver rapid insertion and dynamic compression across the fusion site with enhanced multiplanar strength and stability. The HyperPlate™ XM Dynamic Com

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated June 16, 2026 to its short form base shelf prospectus dated October 31, 2025.Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - HIVE Digital Technologies Ltd. (TSX:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) (the "Company" or "HIVE"), through its wholly owned subsidiary BUZZ High Performance Computing Inc. ("BUZZ HPC"), today announced a landmark sovereign AI infrastructure deal involving Bell Canada (TSX:BCE) (NYSE:BCE) and Cohere Inc., marking a significant milestone in Canada's AI infrastructure ecosystem.The collaboration brings togeth

Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora's ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis PigmentosaEncinitas, California--(Newsfile Corp. - June 18, 2026) - Kiora Pharmaceuticals (NASDAQ:KPRX) today announced preclinical data showing that KIO-300, part of the company's novel ion channel modulator platform, significantly suppressed seizure-associated electrophysiological activity in an ex vivo temporal lobe epilepsy (TLE) model. The findings were presented in a poster at the Epilepsy Foundatio

The Company invites individual and institutional investors, as well as advisors and analysts with an interest in Phio Pharmaceuticals, to attend the live, interactive presentation and one-on-one meetingsKing of Prussia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762 for the treatment of cutaneous c

BOSTON, June 18, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced plans to open a new large-format retail store in Princeton, New Jersey. The location, expected to open in 2027, marks an important step in expanding Wayfair's presence across the Northeast and serving customers throughout New Jersey, New York and Pennsylvania. "Opening in Princeton represents another exciting milestone as we continue expanding Wayfair's physical retail presence across America," said Liza Lefkowski, vice president of merchandising and stores at Wayfair. "We're creating a destination where customers can explore inspiring spaces, experience the quality and breadth o

HOLON, Israel, June 18, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today presented a trial-in-progress poster on the MAIA-ovarian adaptive platform trial of COM701, a potential first-in-class anti-PVRIG antibody, at the ESMO Gynaecological Cancers Congress 2026, in Copenhagen, Denmark. "We believe there is a strong biologic and clinical rationale for the MAIA-ovarian trial in relapsed platinum-sensitive ovarian cancer, where no standard of care for this maintenance setting exists," said Eran Ophir, Ph.D., President and CEO of Compugen. "COM701 is well tolera

TORONTO, June 18, 2026 /CNW/ - CIBC (TSX:CM) (NYSE:CM) – CIBC today announced it will terminate the ETF Series of the CIBC Sustainable Investment Strategies (the "Funds"), on or about November 27, 2026 (the "Termination Date"). CIBC also announced a change to the risk rating of the CIBC Dividend Income Fund effective on or about June 18, 2026. ETF Series terminationCboe ETF Series tickerFund name CSCPCIBC Sustainable Canadian Core Plus Bond Fund – ETF Series CSCECIBC Sustainable Canadian Equity Fund – ETF Series CSGECIBC Sustainable Global Equity Fund – ETF Series CSCBCIBC Sustainable Conservative Balanced Solution – ETF Series

BEAM-304 Development Approach Has Potential to Create Transformative, One-time Therapies for the Majority of Patients with PKU  BEAM-304 Program Designed as Platform-based Approach Reflecting Emerging FDA Guidance for Accelerated Development of Genome Editing Therapies New Preclinical Data for BEAM-304 to be Presented at FASEB Genome Engineering: Research and Applications Conference CAMBRIDGE, Mass., June 18, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) has cleared the investigational new drug (IND) applic

In a new investor Q&A, the four-decade market veteran lays out a simple case: VENU may be "significantly undervalued" in the market and VENU's real estate portfolio on an as-completed basis is worth far more than reflected on VENU's books Venu Holding Corporation ("VENU" or the "Company") (NYSE:VENU), an owner, operator, and developer of premium live entertainment destinations, today released a recorded investor Q&A between Founder, Chairman, and CEO J.W. Roth and veteran investor, retired hedge fund manager, and widely followed market analyst Shah Gilani, Founder and Chief Investment Strategist at ANNSR Market Analytics. You can watch the interview here. This press release features mult

The Phase 3 TRIDENT trial enrolled patients with glioblastoma prior to the initiation of chemoradiation and evaluated the benefit of initiating Tumor Treating Fields (TTFields) therapy at the start of chemoradiation compared to initiating TTFields therapy in the maintenance phase TRIDENT did not meet its primary endpoint of demonstrating a statistically significant increase in overall survival for patients in the intent-to-treat (ITT) population who initiated TTFields therapy at the start of chemoradiation Results from TRIDENT demonstrated a durable survival benefit for patients in both arms of the trial, no new safety signals were observed, and early initiation of TTFields therapy was

Registrational Ph2b/3 Trial of Zelicapavir to Initiate in High-Risk Adults with RSV in 4Q 2026, with Topline Phase 2b Data Expected in 2027 Phase 2b Trial of Zelicapavir to Initiate in Pediatric Patients with RSV in 3Q 2026, with Topline Data Expected in 2027 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced it is advancing zelicapavir into a registrational Phase 2b/3 clinical trial in adults at high risk of severe outcomes from RSV infection after a successful End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA). The Phase 2b

New data solution enhances usability, transparency and decision-making amid UK and EU transparency reforms MarketAxess Holdings Inc. (NASDAQ:MKTX) today announced the launch of TraX® Tape, a data solution that delivers a clean, consolidated view of bond market activity, enriched with additional context and real-time insights. The launch comes as UK and EU transparency reforms increase the availability of bond trading data while adding complexity to how that data is reported and interpreted. TraX Tape addresses these challenges by providing a single, standardised feed that consolidates and enhances market data, enabling clients to interpret trading activity more efficiently and with grea

NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. ("REFI") (NASDAQ:REFI), a commercial mortgage real estate investment trust, and Chicago Atlantic BDC, Inc. (the "LIEN") (NASDAQ:LIEN), a specialty finance company that has elected to be regulated as a business development company ("BDC"), today announced they have entered into a definitive merger agreement (the "Merger Agreement") under which REFI will elect to be regulated as a BDC, and merge with and into LIEN in an all-stock, strategic combination (the "Merger"). Upon closing of the Merger, LIEN will be the surviving public entity and will continue to operate as a BDC and trade on the Nasdaq Global Se

VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (NASDAQ:AEC, TSX.V: AEC, FRANKFURT: 0AD)) ("Anfield" or the "Company"), following its May 4th news release, is pleased to report that is has filed its combined preliminary economic assessment ("PEA") titled, "The Shootaring Canyon Mill and Tributary Mines, Utah and Colorado, USA, Preliminary Economic Assessment" on SEDAR+. The PEA incorporates its Utah-based Velvet-Wood uranium and vanadium project ("Velvet-Wood"), its Colorado-based Slick Rock uranium and vanadium project ("Slick Rock") and six of the nine mines which comprise the West Slope complex ("West Slope Mines"). These eight projects, being Velvet-W

ATLANTA, June 18, 2026 (GLOBE NEWSWIRE) -- Americold Realty Trust (NYSE:COLD), a global leader in temperature-controlled logistics, real estate and value-added services, today announced the grand opening of its import-export hub at Port Saint John in New Brunswick, Canada during Port Days 2026, the Port's annual maritime and industry conference. Developed in collaboration with DP World and Canadian Pacific Kansas City (TSX:CP) (NYSE:CP) (CPKC), the facility is the first of its kind globally to combine Americold's cold storage operations, DP World's maritime logistics capabilities, and CPKC's rail network in a single location. Together, these capabilities create a more direct and reliable

DENVER, June 18, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ:SMPL) ("Simply Good Foods" or the "Company"), a leader in the Nutritional Snacking category, today announced it will report financial results for the third quarter of Fiscal Year 2026 on Thursday, July 9, 2026. A press release will be issued that morning, followed by a live conference call beginning at 6:30 a.m. Mountain Time (8:30 a.m. Eastern Time). Participating on the call will be Joe Scalzo, President and Chief Executive Officer and Chris Bealer, Chief Financial Officer. Investors interested in participating in the live call can dial 877-407-0792 from the U.S., or 201-689-8263 from international locations